Molecular, Cellular, and Blood Biomarkers in Acute Ischemic Stroke
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 5236
Special Issue Editor
2. Department of Neurology & Neurophysiology, Liverpool Hospital & South West Sydney Local Health District (SWSLHD), Liverpool, NSW 2170, Australia
Interests: neurology; biomarkers; clinical trials; cardiovascular diseases; stroke; telemedicine; COVID-19; neuropathology; neuroimmunology; neurodegenerative diseases; neurophysiology; clinical medicine; clinical neuroscience; public health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Stroke is a leading cause of death and disability in the world. The advent of thrombolysis and endovascular thrombectomy has revolutionized the field of stroke medicine. However, despite these advances, unfortunately, these treatments are accessed by, or available to, only a limited subgroup of patients. Several stroke patients live with lifelong disabilities. In this context, the identification of molecular, cellular, and blood biomarkers could contribute to the diagnosis, prognosis, and management of acute ischemic stroke patients. From transcriptomic signatures based on the detection of differential expression of genes, brain clot composition, and novel imaging biomarkers to the application of machine learning to epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of acute ischemic stroke could assist in stratifying patients into groups and inform prognostic and therapeutic strategies. We invite submissions on a broad range of topics – including but not limited to exploratory or fundamental scientific studies, pre-clinical, cross-sectional studies, clinical trials, position papers/recommendations, hypothesis/perspective, systematic and narrative/comprehensive review on the novel, emerging and existing molecular, cellular and blood biomarkers in acute ischemic stroke.
Dr. Sonu M. M. Bhaskar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stroke
- cerebrovascular disorders
- reperfusion
- biomarkers
- discovery
- translational neuroscience
- blood
- molecular
- imaging
- cerebral ischemia
- genomics
- proteomics